Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

[News]

A new study posted to the medRxiv* preprint server studies the neutralizing antibody response in cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and various non-Hodgkin’s lymphomas (NHL), post-reception of two doses of messenger RNA (mRNA) vaccines.

More... (https://www.news-medical.net/news/20211025/Cancer-patients-have-impaired-antibody-responses-to-COVID-19-mRNA-vaccines.aspx)